143 related articles for article (PubMed ID: 26912327)
1. Evaluation of serum and tissue levels of VAP-1 in colorectal cancer.
Ward ST; Weston CJ; Shepherd EL; Hejmadi R; Ismail T; Adams DH
BMC Cancer; 2016 Feb; 16():154. PubMed ID: 26912327
[TBL] [Abstract][Full Text] [Related]
2. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
[TBL] [Abstract][Full Text] [Related]
3. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
4. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
5. Association of HMGB1 with oxidative stress markers and regulators in PDR.
Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular adhesion protein-1 predicts all-cause mortality and cancer-related mortality in subjects with colorectal cancer.
Li YI; Hung JS; Yu TY; Liou JM; Wei JN; Kao HL; Chuang LM; Shun CT; Lee PH; Lai HS; Su CY; Li HY; Liang JT
Clin Chim Acta; 2014 Jan; 428():51-6. PubMed ID: 24211727
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular adhesion protein-1 in atopic eczema.
Madej A; Reich A; Orda A; Szepietowski JC
Int Arch Allergy Immunol; 2006; 139(2):114-21. PubMed ID: 16361866
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
[TBL] [Abstract][Full Text] [Related]
9. Vascular adhesion protein-1 in human ischaemic stroke.
Airas L; Lindsberg PJ; Karjalainen-Lindsberg ML; Mononen I; Kotisaari K; Smith DJ; Jalkanen S
Neuropathol Appl Neurobiol; 2008 Aug; 34(4):394-402. PubMed ID: 18005095
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.
Yoshida S; Murata M; Noda K; Matsuda T; Saito M; Saito W; Kanda A; Ishida S
Jpn J Ophthalmol; 2018 Mar; 62(2):256-264. PubMed ID: 29392528
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
12. Origins of serum semicarbazide-sensitive amine oxidase.
Stolen CM; Yegutkin GG; Kurkijärvi R; Bono P; Alitalo K; Jalkanen S
Circ Res; 2004 Jul; 95(1):50-7. PubMed ID: 15178639
[TBL] [Abstract][Full Text] [Related]
13. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
Yanaba K; Yoshizaki A; Muroi E; Ogawa F; Shimizu K; Sato S
Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
[TBL] [Abstract][Full Text] [Related]
15. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.
Salmi M; Stolen C; Jousilahti P; Yegutkin GG; Tapanainen P; Janatuinen T; Knip M; Jalkanen S; Salomaa V
Am J Pathol; 2002 Dec; 161(6):2255-62. PubMed ID: 12466139
[TBL] [Abstract][Full Text] [Related]
16. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis.
Weston CJ; Shepherd EL; Claridge LC; Rantakari P; Curbishley SM; Tomlinson JW; Hubscher SG; Reynolds GM; Aalto K; Anstee QM; Jalkanen S; Salmi M; Smith DJ; Day CP; Adams DH
J Clin Invest; 2015 Feb; 125(2):501-20. PubMed ID: 25562318
[TBL] [Abstract][Full Text] [Related]
17. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy.
Murata M; Noda K; Fukuhara J; Kanda A; Kase S; Saito W; Ozawa Y; Mochizuki S; Kimura S; Mashima Y; Okada Y; Ishida S
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4055-62. PubMed ID: 22618595
[TBL] [Abstract][Full Text] [Related]
18. Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients.
Madej A; Reich A; Orda A; Szepietowski JC
J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):72-8. PubMed ID: 17207171
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
[TBL] [Abstract][Full Text] [Related]
20. VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke.
Hernandez-Guillamon M; Solé M; Delgado P; García-Bonilla L; Giralt D; Boada C; Penalba A; García S; Flores A; Ribó M; Alvarez-Sabin J; Ortega-Aznar A; Unzeta M; Montaner J
Cerebrovasc Dis; 2012; 33(1):55-63. PubMed ID: 22133888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]